Drug Approval | July 02, 2024
Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer
Imfinzi also recommended for patients with mismatch repair deficient disease
Imfinzi also recommended for patients with mismatch repair deficient disease
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
This plant is located at Baddi, Himachal Pradesh spread over an area of 2.85 acres
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Subscribe To Our Newsletter & Stay Updated
